Impact of baseline C-reactive protein levels on the response to secukinumab in ankylosing spondylitis: 3-year pooled data from two phase III studies

Author(s):
Braun, J.; Deodhar, A.; Landewe, R.; Baraliakos, X.; Miceli-Richard, C.; Sieper, J.; Quebe-Fehling, E.; Martin, R.; Porter, B.; Gandhi, K.K.; Heijde, D. van der; Gallagher, J.; Maity, N.; Pillai, N.; MEASURE 1 Study Grp; MEASURE 2 Study Grp
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-07-31
Language
English
Is part of
RMD Open (2018), No. 2
hdl
1887/78488
doi
10.1136/rmdopen-2018-000749